危重患儿镇静减量机会的依从性与住院时间
减量机会定义为12小时内任何镇静药按需给药0或1次,减量依从性为识别出的减量机会中实际执行减量(减量或停药)的百分比。总体依从性仅28%,依从性每提高10%与ICU住院缩短2.3天、总住院缩短3.6天、镇静输注缩短1.1天及阿片类、苯二氮䓬类、α2激动剂累积暴露降低相关。提高减量依从性可能是缩短住院和减少镇静暴露的可干预靶点。
要点
- 减量机会定义为12小时内任何镇静药按需给药0或1次,减量依从性为机会中执行减量或停药的百分比,总体仅28%。
- 依从性每提高10%,阿片类累积暴露中位降低3.5 mg/kg、苯二氮䓬类降低3.4 mg/kg、α2激动剂降低27.7 µg/kg。
- 每例ICU住院减量机会中位30次(IQR 13-68),错过减量机会中位72%(IQR 51%-86%),提示床旁常规评估减量机会不足。
适用人群与场景
- 4个儿科学术医学中心ICU中2011年1月1日至2024年12月31日入院、累计镇静输注暴露超过48小时的患儿;排除新生儿ICU住院。
诊断标准与关键阈值
- 减量机会定义:12小时内任何镇静药按需给药0或1次。
- 减量依从性定义:识别出的减量机会中执行减量动作(剂量减少或停药)的百分比,按ICU住院层面计算。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 多变量线性回归模型校正中心、年龄和性别。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究(2011-2024年数据,2025年2-11月提取分析)。
- 局限:观察性设计不能证明因果关系;减量机会与依从性为操作性定义;校正变量仅中心、年龄和性别。
对床旁实践的改变
- 床旁应常规按12小时窗口评估镇静减量机会(按需给药0或1次即视为机会),并记录是否执行减量或停药,因原文显示依从性仅28%、错过机会中位72%。
- 提高减量依从性与ICU住院和总住院缩短独立相关,可作为缩短住院和减少镇静暴露的可干预质控靶点。
- 原文为观察性关联,不能据此推断提高依从性必然缩短住院,需前瞻性验证。
指南或共识出处
- JAMA Network Open
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Prolonged sedative exposure in pediatric intensive care units (ICUs) is associated with adverse outcomes including delirium, withdrawal, and neurodevelopmental impairment. Clinical guidelines recommend timely weaning, but adherence to weaning opportunities and its association with clinical outcomes is unknown.
OBJECTIVES: To evaluate adherence to sedative weaning opportunities and examine the association between weaning adherence and clinical outcomes among pediatric ICU patients.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter cohort study included ICU patients at 4 pediatric academic medical centers admitted between January 1, 2011, and December 31, 2024, with greater than 48 hours of cumulative sedative infusion exposure. Data extraction and analyses were performed between February and November 2025. Neonatal ICU stays were excluded.
EXPOSURE: Weaning adherence, defined as the percentage of identified opportunities to wean from sedation that resulted in weaning actions (dose decreases or discontinuations), calculated at the ICU encounter level. An opportunity was defined as 0 or 1 as-needed doses of any sedative in a 12-hour period.
MAIN OUTCOMES AND MEASURES: The primary outcomes were ICU and hospital length of stay. Secondary outcomes included infusion duration and cumulative sedative dose of each drug class. Multivariable linear regression models adjusted for center, age, and sex examined associations between weaning adherence and outcomes.
RESULTS: The cohort included 15 747 ICU encounters from 12 737 patients (median age, 1.1 years [IQR, 0.2-6.5 years]; 56% of encounters among male patients). Median ICU length of stay was 13 days (IQR, 7-25 days) and median hospital length of stay was 26 days (IQR, 14-55 days). Among a median of 30 (IQR, 13-68) opportunities to wean per ICU encounter, overall adherence to weaning opportunities was 28% (IQR, 14%-49%), while missed weaning opportunities were common (median, 72%; IQR 51%-86%). Higher weaning adherence was associated with shorter median ICU length of stay (-2.3 days [IQR, -2.4 to -2.2 days] per 10% increase; P < .001) and shorter median total hospital length of stay (-3.6 days [IQR, -4.0 to -3.4 days] per 10% increase; P < .001). Higher weaning adherence was associated with shorter median sedative infusion duration for all sedative classes combined (-1.1 days [IQR, -1.2 to -1.0 days] per 10% increase in adherence; P < .001) and lower median cumulative exposure to opioids (-3.5 mg/kg [IQR, -3.8 to -3.2 mg/kg]; P < .001), benzodiazepines (-3.4 mg/kg [IQR, -3.8 to -3.0 mg/kg]; P < .001), and α2 agonists (-27.7 µg/kg [IQR, -30.2 to -25.3 µg/kg]; P < .001).
CONCLUSIONS AND RELEVANCE: In this multicenter cohort, adherence to sedative weaning opportunities was low. Higher weaning adherence was independently associated with shorter ICU and hospital lengths of stay and reduced sedative exposure. Improving adherence to sedative weaning opportunities may represent a modifiable target for reducing length of stay and sedative exposure.
参考来源
- Smith TM, Ducatez F, Achuff BJ, et al. Adherence to Sedative Weaning Opportunities and Length of Stay for Critically Ill Children. JAMA Netw Open. 2026. PMID: 42627664. doi:10.1001/jamanetworkopen.2026.29399
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。